Literature DB >> 35316542

'Home-school toes' - a case series of paediatric perniosis presentations.

Natalie Teh1, Victoria Pennington1,2, Linda K Martin1,2.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35316542      PMCID: PMC9314131          DOI: 10.1111/ajd.13827

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.481


× No keyword cloud information.
Dear Editor, Coronavirus disease (COVID‐19) has been associated with varying cutaneous manifestations in children, ranging from viral exanthema to cutaneous vasculitis. Among such dermatologic presentations are ‘COVID toes’, a chilblain‐like phenomenon described in some COVID‐positive patients who may be otherwise asymptomatic for infection. This entity remains controversial, as most patients reported in a series of ‘COVID toes’ did not have microbiologically confirmed infection. , , Reports of SARS‐Cov2 viral particles on electron microscopy of perniosis specimens have been disputed. Perniosis, or chilblain, is a common inflammatory dermatosis usually affecting the dorsal feet or hands following exposure to damp, cold, nonfreezing conditions, manifesting clinically as purpuric plaques and histologically characterised by a lymphocytic vasculitis. Exposure to cold environments may cause persistent vasoconstriction in predisposed patients, resulting in hypoxaemia and a secondary cutaneous inflammatory reaction. We present a retrospective case series of children and adolescents who presented to the Emergency Department at Sydney Children's Hospital, Randwick, New South Wales (NSW), Australia, with skin manifestations of perniosis in the setting of COVID‐19 ‘remote‐learning’ in winter 2021. Patients were identified through interrogation of the Sydney Children's Hospital Emergency Department database, including a review of all presentations related to hands and feet. Medical records of patients under 18 years of age who presented with signs and symptoms of perniosis during the winter months of 2021 (June–August) were included, corresponding to the NSW school term three period of ‘remote‐learning’, which commenced on 12 July 2021. In total, eleven patients (five male and six female) were identified. Their clinical data are summarised in Table 1. Ethics approval was granted by the Sydney Children's Hospitals Network Human Research Ethics Committee (CCR2021/31). Written consent was obtained from all patients prior to study inclusion.
Table 1

Clinical characteristics of eleven paediatric patients with perniosis

Month of presentation in 2021EthnicityAge (years)GenderChilblain localisationSARS‐CoV‐2 PCR testLevel of activity (Same/more/less than usual)Home‐schooledRegular shoe/sock/glove wearing
JulyAsian3FFeetNoSameYesYes
JulyAsian13FHands and feetNoSameYesYes
JulyCaucasian11FFeetNegativeLess than usualYesNo
AugustMixed race (Caucasian/Asian)11FHands and feetNegativeSameYesYes
AugustCaucasian10MFeetNegativeLess than usualYesNo
AugustCaucasian14FHands and feetNegativeSameYesNo
AugustCaucasian15MHands and feetNegativeLess than usualYesYes
AugustCaucasian14MFeetNoLess than usualYesYes
AugustAsian12MFeetNegativeLess than usualYesNo
AugustMixed race (Caucasian/Asian)9FFeetNoLess than usualYesNo
AugustCaucasian15MFeetNegativeLess than usualYesNo
Clinical characteristics of eleven paediatric patients with perniosis The mean age of presenting patients was 11 years (range, 3–15 years), and the mean duration of symptoms prior to presentation was fifteen days. There were no perniosis presentations in June, with three cases in July and eight in August. Of the eleven patients included, seven reported only plantar involvement, while four had both hands and feet affected. Two patients had experienced previous episodes of perniosis. A known family history of perniosis was reported in two patients. Discolouration was the most common sign experienced, with 55% of patients reporting, followed by pain, swelling, pruritus and blistering (Figs 1 and 2). Three patients had concomitant systemic symptoms (fever, fatigue, vomiting or coryzal symptoms). Initial diagnosis in emergency was variable, with multiple children undergoing extensive investigations, including two children having X‐rays, five children having blood investigations for vasculitis and one child undergoing biopsy, which confirmed lymphocytic vasculitis with overlying epidermal necrosis, consistent with perniosis.
Figure 1

Acral perniosis in patient 4. Clinical photographs of the plantar aspects of the left (panel a) and right (panel b) feet illustrate multifocal erythematous nodules with central vesiculation, and clinical photographs of the dorsal aspects of the right foot (panel c) and left foot (panel d) illustrate violaceous discolouration and swelling of all digits. [Colour figure can be viewed at wileyonlinelibrary.com]

Figure 2

Multifocal purpuric nodules on weight‐bearing areas of toes (panel a) (patient 7). Reticulate erythema and urticated papules on the dorsal aspect of the right hand and fingers (panel b). [Colour figure can be viewed at wileyonlinelibrary.com]

Acral perniosis in patient 4. Clinical photographs of the plantar aspects of the left (panel a) and right (panel b) feet illustrate multifocal erythematous nodules with central vesiculation, and clinical photographs of the dorsal aspects of the right foot (panel c) and left foot (panel d) illustrate violaceous discolouration and swelling of all digits. [Colour figure can be viewed at wileyonlinelibrary.com] Multifocal purpuric nodules on weight‐bearing areas of toes (panel a) (patient 7). Reticulate erythema and urticated papules on the dorsal aspect of the right hand and fingers (panel b). [Colour figure can be viewed at wileyonlinelibrary.com] Although a SARS‐CoV‐2 PCR test was not performed on four patients, seven patients returned negative results. Two referring general practitioners and two families expressed concerns regarding ‘COVID toes’; however, no patient tested positive for SARS‐CoV‐2 at the time of presentation. All patients were home‐schooled during winter 2021. Most patients reported a reduced level of activity compared to their normal baseline (63%). Although heating at home was present for all patients, most patients (7/11) reported not wearing shoes or socks during the home‐school period. Four patients recognised the association with their symptoms and cold exposure. Since the start of the COVID‐19 pandemic, practitioners have noted an increase in perniosis presentations. Patients are now presenting to health professionals, concerned that acrally‐distributed dermatoses may be a COVID‐19 manifestation. A prospective study by Neri et al. suggested that a cluster of eight paediatric primary perniosis presentations observed in March–April 2020 was attributed to increased cold exposure affecting predisposed patients. Behavioural and environmental changes due to lockdowns, including contact with cold floors (87%), unheated apartments (62%) and walking barefoot (100%), may have contributed to increased cold exposure. Similarly, a survey of predominantly adolescent and adult patients who presented with perniosis demonstrated that most patients reported reduced physical activity (61.3%) and shoe‐wearing during lockdown (87.1%). Our series demonstrates increasing numbers of perniosis presentations from July through August 2021, paralleling the remote‐learning in greater Sydney commencing on 12 July. It is unclear whether the presentations are related to lifestyle changes during home‐schooling or heightened community perception of perniosis as a possible COVID‐19 manifestation. Given the lack of laboratory‐confirmed SARS‐CoV‐2 19 infection and the presence of social, environmental and behavioural risk factors, we propose that the increased presentations of paediatric perniosis over the winter months may represent ‘home‐school toes’ resulting from lifestyle changes associated with lockdowns and home‐schooling during the pandemic. Our data support no evidence of a causal relationship between COVID‐19 and perniosis.

Funding

LKM is supported by the Warwick L Morison Professorship in Dermatology.

CONFLICT OF INTEREST

This manuscript has no conflict of interest.

ETHICAL APPROVAL

Ethics approval for the study was granted by the Sydney Children's Hospitals Network Human Research Ethics Committee (CCR2021/31).

PATIENT CONSENT FOR PUBLICATION STATEMENT

All patients provided written consent for the publication of this manuscript.
  9 in total

1.  Chilblains (perniosis).

Authors:  D K Goette
Journal:  J Am Acad Dermatol       Date:  1990-08       Impact factor: 11.527

Review 2.  Idiopathic chilblains.

Authors:  Shraddha Prakash; Michael H Weisman
Journal:  Am J Med       Date:  2009-12       Impact factor: 4.965

3.  Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic.

Authors:  Anne Herman; Caroline Peeters; Alexia Verroken; Isabelle Tromme; Dominique Tennstedt; Liliane Marot; Claire Dachelet; Damien Gruson; Cedric Hermans; Marie Baeck
Journal:  JAMA Dermatol       Date:  2020-09-01       Impact factor: 10.282

4.  Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries.

Authors:  Esther E Freeman; Devon E McMahon; Jules B Lipoff; Misha Rosenbach; Carrie Kovarik; Junko Takeshita; Lars E French; Bruce H Thiers; George J Hruza; Lindy P Fox
Journal:  J Am Acad Dermatol       Date:  2020-05-30       Impact factor: 11.527

5.  Pediatric COVID toes and fingers.

Authors:  Merav Koschitzky; Ryan Rivera Oyola; Mary Lee-Wong; Brian Abittan; Nanette Silverberg
Journal:  Clin Dermatol       Date:  2021-01-14       Impact factor: 3.541

6.  Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic.

Authors:  Cristiana Colonna; Giovanni Genovese; Nicola Adriano Monzani; Marina Picca; Francesca Boggio; Raffaele Gianotti; Angelo Valerio Marzano
Journal:  J Am Acad Dermatol       Date:  2020-06-10       Impact factor: 11.527

7.  Cutaneous manifestations in COVID-19: Lessons learned from current evidence.

Authors:  Poonkiat Suchonwanit; Kanchana Leerunyakul; Chaninan Kositkuljorn
Journal:  J Am Acad Dermatol       Date:  2020-04-24       Impact factor: 11.527

8.  SARS-CoV-2 has not been detected directly by electron microscopy in the endothelium of chilblain lesions.

Authors:  J K Brealey; S E Miller
Journal:  Br J Dermatol       Date:  2020-12-16       Impact factor: 11.113

9.  Major cluster of paediatric 'true' primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown.

Authors:  I Neri; A Virdi; I Corsini; A Guglielmo; T Lazzarotto; L Gabrielli; C Misciali; A Patrizi; M Lanari
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-03       Impact factor: 9.228

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.